Nayzilam side effects by duration, gender and age - a phase IV clinical study of FDA data
Summary:
Side effects are reported by people who take Nayzilam. Common side effects include seizure among females, and seizure among males.
The phase IV clinical study is created by eHealthMe based on 508 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
508 people who take Nayzilam and have side effects are studied.
What is Nayzilam?
Nayzilam has active ingredients of midazolam. Currently, eHealthMe is studying from 511 Nayzilam users.
Number of Nayzilam reports submitted per year:
Nayzilam side effects by time on the drug *:
Nayzilam side effects by gender *:
Nayzilam side effects by age *:
* Approximation only. Some reports may have incomplete information.
Do you take Nayzilam?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on midazolam (the active ingredients of Nayzilam) and Nayzilam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies
Alternative drugs to, pros and cons of Nayzilam:
- Nayzilam (511 reports)
Common Nayzilam side effects:
All Nayzilam side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Gabapentin and Terramycin drug interaction - 4 seconds ago
- Viibryd and Brimonidine Tartrate drug interaction - 4 seconds ago
- Precedex and Zometa drug interaction - 5 seconds ago
- Msm and Nifedipine drug interaction - 20 seconds ago
- Erlotinib Hydrochloride and Aphagia - 22 seconds ago
- Atropine Sulfate and Diabetes - 22 seconds ago
- Loratadine And Pseudoephedrine Sulfate and Breathing Difficulty - 29 seconds ago
- Myrbetriq and Aggrenox drug interaction - 29 seconds ago
- Ofloxacin and Ogen drug interaction - 33 seconds ago
- Carpine and Escherichia Urinary Tract Infection - 36 seconds ago